Item 2.02.                   Results of Operations and Financial Condition.

On January 30, 2020, Edwards Lifesciences Corporation, a Delaware corporation ("Edwards"), issued a press release setting forth Edwards' financial results for the fourth quarter of 2019. A copy of the press release is furnished as Exhibit 99.1, and is incorporated herein by reference.

The information furnished under this Item 2.02, including Exhibit 99.1, shall not be deemed to be "filed" for purposes of the Securities Exchange Act of 1934, as amended.




Item 9.01.                   Financial Statements and Exhibits.

  (d)  Exhibits

       Press release, dated January 30, 2020, reporting Edwards' financial
  99.1 results for the fourth quarter of 2019.




                                       2

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses